Prev Close | 62.40 |
Day Low/High | 62.13 / 63.59 |
52 Wk Low/High | 56.56 / 85.97 |
Prev Close | 62.40 |
Day Low/High | 62.13 / 63.59 |
52 Wk Low/High | 56.56 / 85.97 |
Exchange | NASDAQ |
Shares Outstanding | 1253.53B |
Market Cap | 78.22B |
P/E Ratio | 63.67 |
Div & Yield | N.A. (N.A) |
The markets started the day like Usain Bolt at the start of a 100-meter race. But, unlike Bolt, the finish wasn't as strong as the start. I thought one of the day's features was the reversal in bond yields, particularly after the good data. The...
Drug giants with money to spend and a friendlier regulatory environment should spur deals.
"Who you tryin' to get crazy with, 'ese? Don't you know I'm loco?..." -- Cypress Hill, Insane in the Brain 2017 will be the year of "The Dude." My favorite large-cap long Allergan and short Caterpillar for next year. AGN closed up by $4(!) wh...
If M&A picks up and Trump doesn't tweet about excessively high drug prices, there should be bounce.
If M&A picks up and Trump doesn't tweet about excessively high drug prices, there should be bounce.
"First gear, it's all right (Honda, Honda, go faster, faster) Second gear, I'll lean right (Honda, Honda, go faster, faster) Third gear, hang on tight (Honda, Honda, go faster, faster) Faster, it's all right." -- Beach Boys, "Little Honda" With a b...
We touched briefly on housing in our first post this morning. There are still some cheap home-building stocks if the housing market continues to improve, which I expect as I believe economic growth will pick up in 2017. I have done well with this se...
Here's why Gilead and Celgene should finally reward their shareholders next year.
"Everyone here likes the bounce." -- President-elect Donald Trump (said in a meeting today at Trump Tower with tech executives) A good day for the ursine crowd but not so good for the bullish cabal as they had a bad day -- for a change. (Yes, I am w...
There's a reason why FANG is back -- though it never really went away.
The long downtrend is looking mature.
Was yesterday "FOMO" or something else? I waited and then moved on the volatility trade. "How many syllables Mario?" (A Putney Swope reference!) Wall Street is now a fear-free zone. Mark Hanson on negative homeowners' equity. Shorted ...
The 'Enterprise Value Growth and Income' stock-picking model should be quite effective in 2017, too.
If the market is going to overreact to every new missive from Trump, I plan to take advantage.
It can take many months or quarters before the market recognizes the value of a downtrodden name.
"Well, they call you lady luck But there is room for doubt At times you have a very un-lady-like way Of running out..." -- Guys and Dolls, Luck Be A Lady (Frank Sinatra) Trump will not likely Make Twitter Great Again. I, bear. Explaining my pr...
What a strange day -- maybe even ominous. This table tells it all. The divergences I have been mentioning this week intensified today, with the technology-laden Nasdaq taken out to the shed and the Russell 2000 Index trading lower for the third...
What's in, what's out and who should thrive in the new political landscape.
In looking for shorts there is one important and underlying factor that governs my selection process: I try through rigorous analysis to identify sectors and companies with intermediate-term prospects that are deteriorating relative to consensus exp...
It may be time to embrace the contrary. First issue (!!): The Palm Beach Chronicles. My weekly (brief) technical review of the markets -- cooling off ahead? BTIG's Stockton is bullish and so, as I have expressed, are most others! Campbell ...
Small-caps could also benefit from abating tax-loss selling.
Investors in biotech stocks appear to be happy with a Trump win and Mizuho's senior biotech analyst says companies in the sector could continue to climb in 2017.
It's not a joke. It's a rope, Tuco. Now I want you to get up there and put your head in that noose. -- Blondie in "The Good, the Bad and the Ugly" I did no trading today, and there will be no "Takeaways" today. As expected, the markets have basicall...
With the election resolved, biotech could be ripe for consolidation.
I would look for GILD to try to stabilize in the $70-$80 area before a more durable uptrend.
At the end of the day! Don't run with the crowd: Embrace contrary and second-level thinking instead. Extreme policy uncertainty. More Howard Marks. Less Bill Miller. My little sister! Graf wrote a goodie. The movie was in revers...
Some potential positives today: Strength in the Russell Index. Improving breadth. Improving Clinton odds by "538" and the London betting parlors. A great deal of pushback to my idea of a trading rally. Turnaround in large-cap biotech (Allergan , Cel...